Related Experiment Videos
SynCar: an approach to automated synthesis
Angelika Weber1, Erich von Roedern, Hans Ulrich Stilz
1Chemical Scaffold and Automated Synthesis Unit, Aventis Pharma Deutschland GmbH, a company of the sanofi-aventis group, 65926 Frankfurt am Main, Germany.
Journal of Combinatorial Chemistry
|March 15, 2005
Summary
This study presents a novel automated system for solution-phase synthesis, addressing a key challenge in organic chemistry. The integrated platform enhances efficiency and reliability for drug discovery library production.
Area of Science:
- Organic Chemistry
- Drug Discovery
- Automation Engineering
Background:
- Automating manual solution-phase synthesis presents a significant challenge in organic chemistry.
- Modern drug discovery requires high-purity compound libraries (50-250 compounds, 10-100 mg scale) with short cycle times and high capacity.
- Existing systems often lack the flexibility and throughput needed for efficient library generation.
Purpose of the Study:
- To design and develop a novel, integrated, and automated system for solution-phase synthesis.
- To meet the demands of modern drug discovery for high-purity compound libraries with enhanced efficiency and throughput.
- To create a flexible and scalable platform for parallel chemical synthesis.
Main Methods:
- Development of a novel system comprising independent modular workstations connected by a shuttle transfer system.
- Integration of synthesis (temperature control, liquid handling), filtration, extraction, evaporation, weighing, solid-phase extraction, and HPLC/MS analysis capabilities.
- Implementation of parallel processing of four reactions per shuttle, enabling continuous loading and customizable workflows.
Main Results:
- The developed system successfully integrates multiple solution-phase synthesis steps into a single automated platform.
- Achieved high flexibility and high throughput, enabling efficient production of compound libraries.
- Demonstrated the capability for parallel processing and continuous operation, significantly reducing cycle times.
Conclusions:
- The novel automated system effectively addresses the unmet challenge of automating solution-phase synthesis.
- The integrated platform offers a flexible, scalable, and high-throughput solution for drug discovery library production.
- This advancement in automation is critical for accelerating lead optimization and target class library development.